At diagnosis, IL10, IL6 and BAFF cytokine serum levels were higher in cHL patients with advanced-stage (Ann Arbor III-IV) lymphoma compared to patients with localized disease (p = 0.002, p = 0.03 and p = 0.01, respectively). This evidence concerns the gene TNFSF13B and lymphoma.